Remy Peptides · For in-vitro laboratory research only. Not for human or veterinary use.Research Use Only
Update History ▾
June 4, 2026: Initial publication built from non-retatrutide search-demand review, existing Remy research standards, product-catalog truth, and peer-reviewed source review.
Research-use-only framing applied throughout in line with Remy editorial standards.
TL;DR - Research Vial Summary

PT-141 is a high-risk keyword because consumer searches often drift into personal-use claims. This product-support page keeps the page in a melanocortin pharmacology lane and routes researchers to the RUO vial without consumer outcome promises. Remy Peptides currently lists PT-141 10mg Vial as In stock, with 10mg · Lyophilized research vial and AED 250-300 pricing shown in the product catalog. This article supports the product page with evidence context, local Dubai/UAE search routing, and COA verification language only.

Compliance note: this is a research-use-only product support article. It does not provide human-use dosing, treatment advice, veterinary guidance, disease-management claims, or administration instructions.

Why This Product-Support Guide Exists

Use the product page for the 10mg vial facts. Use this guide for the melanocortin identity, blood-pressure signal context, and the compliance boundary around consumer claims.

This guide answers common local research-supply searches such as:

For current product facts, start with PT-141 10mg Vial. This article adds the surrounding evidence, supplier-verification, and compliance context around that listing.

Evidence Map and Translation Limits

Bremelanotide/PT-141 has published melanocortin clinical-trial literature and label context, including safety monitoring around blood pressure.[1][2] For Remy Peptides, those sources anchor identity and risk awareness only; the PT-141 vial is listed strictly for in-vitro research.[3]

Research layer What the literature supports How it should inform the product page
Identity PT-141 is bremelanotide, a cyclic melanocortin receptor peptide. Clarifies synonym coverage for search and product routing.
Evidence tier Clinical sources exist for regulated bremelanotide products, including safety monitoring. Supports conservative identity and caution language.
Dubai product intent Local researchers need vial size, AED tier, stock, and COA route. Routes to /product/pt-141-10mg.

Dubai/UAE Product Documentation

For commercial clarity, the live product page remains the source of truth. This article mirrors only stable catalog facts and points researchers back to the current listing before any order or restock check.

Field Current Remy Peptides listing
Product pagePT-141 10mg Vial
Format10mg · Lyophilized research vial
Stock statusIn stock
AED price tierAED 250-300
COA routeCheck the product page and COA library; request lot-specific HPLC documentation when a public batch file is not yet posted.
Use restrictionFor in-vitro laboratory research only. Not for human or veterinary use.

Supplier Checks for Research-Use Buyers

For Dubai and UAE research-supply searches, the cleanest buying checklist is evidence-light and verification-heavy. Before comparing any PT-141 10mg source, confirm:

Remy Peptides centralizes that workflow through the product page, the COA library, and contact verification.

What This Page Does Not Claim

The research record helps define the compound, but it does not turn an RUO vial into a clinical product. Keep these boundaries in view:

Our Research Standards

This article was built from local non-retatrutide search-demand review, existing Remy article standards, live product-catalog data, and peer-reviewed or official source checks. No therapeutic, human-use, or veterinary-use claim is made. Read our editorial policy →

RP
Editorial Review

Editorial Board, Remy Peptides

The Remy Peptides Editorial Board reviews Remy's peptide research library, with a focus on analytical verification, clinical-trial interpretation, and compliance-safe scientific communication.

About the editorial team →

PT-141 10mg Research FAQ

Can Dubai researchers buy PT-141 10mg from Remy Peptides?

Yes. Remy Peptides lists PT-141 10mg Vial as in stock for research-use-only orders in Dubai and the UAE. The live product page is the source of truth for current stock, AED pricing, and COA request details.

What format and price does Remy list for PT-141 10mg?

Remy Peptides lists PT-141 10mg as 10mg · Lyophilized research vial, with current AED tiers shown as AED 250-300. Prices, pack tiers, and orderability can change, so the product page should be checked before any research order.

What evidence does this PT-141 10mg guide cover?

This article summarizes compound identity, the strongest peer-reviewed evidence anchors, and the limits of translating regulated or preclinical findings to a research-use catalog vial. It is an evidence map, not a clinical-use guide.

Is PT-141 10mg sold for human or veterinary use?

No. Remy Peptides products are supplied strictly for in-vitro laboratory research. They are not for human use, veterinary use, diagnosis, treatment, cure, disease management, or personal-use protocols.

Which page should researchers use next?

Use /product/pt-141-10mg for the live product facts, price tier, stock status, image, and COA route. Use the linked Remy research profile or comparison article for deeper mechanism and evidence context.

Sources

  1. Kingsberg SA, Clayton AH, Portman D, et al. Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials. Obstetrics & Gynecology. 2019. PMID: 31599840
  2. Usefulness of ambulatory blood pressure monitoring to assess the melanocortin receptor agonist bremelanotide. Journal of Hypertension. 2017. PMID: 27977473
  3. U.S. National Library of Medicine. DailyMed bremelanotide label search. dailymed.nlm.nih.gov

For current stock, pricing, and COA route, use the live PT-141 10mg Vial page. For wider supplier verification, continue to the peptide COA guide and official contact verification.